This is a snippet of the transcript.Contact Salesto get full access.
If this was a surgeon-driven and care team-driven project, you could see the commitment and a significant increase in procedures. You would start urology first, two or three weeks later, start general, then gynecology. Within two to three months, the system would run four to five days per week, and you could easily see 150 cases in the first year, almost one case per day. If it goes the other way around, with the C-level dictating how things go, you have to reverse engineer the whole project. Surgeons are usually hesitant to start. They need convincing, case observations, and technology demonstrations. A date of installation is set, but teams are not ready yet. Plus, the energy and a chief surgeon who can't sell it as their own project can be annoyed. It complicates things significantly when it's sold from top to bottom, from C-level to surgeons, and not vice versa.
This is a snippet of the transcript.Contact Salesto get full access.
It can go both ways. Usually, if you're trying to sell a robot today, I would say, in the end, the surgeons hold the power. You can educate surgeons to present powerful arguments to the C-level, saying, "We need this now." You have to equip them to become more influential. If they aren't powerful enough with just surgical arguments, we can provide them with a set of arguments to present to their C-level.
This is a snippet of the transcript.Contact Salesto get full access.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.